ÐÓ°ÉÔ´´ excels in mRNA production and lipid nanoparticle (LNP) drug formulation, offering solutions from personalized all the way to commercial scale manufacturing.
Our proprietary manufacturing and formulation processes yield high quality mRNA products with superior tolerability and are highly efficient at all scales.
We have sucessfully conducted in-house production of mRNA and LNPs at a research scale and manufactured these components in-house at GMP-certified facilities for Phase 1 and 2 clinical trials.
Our team has also completed technology transfer of GMP-grade production of mRNA, lipids, and LNPs to multiple global manufacturing sites at commercial level.


​The ÐÓ°ÉÔ´´ Manufacturing Advantage​
Highly efficient manufacturing at all scales from research to commercialization – simplified Platform increases speed to market.​